Disc Sees Promise In Hematology With Former Roche Schizophrenia Candidate

 
• By Joseph Haas
Sun sensitive
Disc's bitopertin shows ability to improve sunlight tolerance in Phase II trial • Source: Shutterstock

More from Clinical Trials

More from R&D